.OS Therapies will certainly provide on the NYSE American sell substitution today by means of a $6.4...
.ALX Oncology's period 2 stomach cancer cells action price has actually damaged. After viewing its o...
.An Additional of Ionis Pharmaceuticals' vital midphase readouts has fallen short of assumptions, tr...
.While Biogen's pharma peers are looking for late-stage possessions along with little bit of threat,...
.Instil Bio has been actually a biotech seeking a pipeline after it ditched its lead resources over ...
.Biogen has handed back legal rights to an early Alzheimer's health condition system to Denali Thera...
.Invite to today's Chutes & Ladders, our roundup of significant leadership hirings, firings and r...
.Tip's effort to alleviate an uncommon genetic health condition has struck an additional drawback. T...
.Vir Biotechnology's second-quarter revenues record wasn't except significant updates. The business ...
.Galapagos has paused application in a trial of a BCMA-directed CAR-T tissue treatment, pumping the ...